Treatment of an HBs-Ag positive stem cell donor with lamivudine to prevent the development of hepatitis B in the recipient [3]

Transplantation

Volumn 78, Issue 5, 2004, Pages 784-785

  Paola, Piccioni ^a   Luca, Laurenti ^a   Michela, Tarnani ^a   Patrizia, Chiusolo ^a   Federica, Sorà ^a   Nicola, Piccirillo ^a   Giuseppe, Leone ^a   Simona, Sica ^a   Antonio, Grieco ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANAMNESIS; CASE REPORT; CONVALESCENCE; DONOR; GRAFT VERSUS HOST REACTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LABORATORY TEST; LETTER; LIVER BIOPSY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; VIRUS LOAD;

HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; LAMIVUDINE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; STEM CELL TRANSPLANTATION; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 4544263373     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000128836.85387.EA     Document Type: Letter

References (5)

1. Papatheodoridis GV, Hadziyannis SJ. Current management of chronic hepatitis B. Aliment Pharmacol Ther 2004; 19: 25.
2. Locasciulli A, Testa M, Valsecchi M, et al. The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group. Transplantation 1999; 68: 1486.
3. Lau GK, Lie KWA, Kwong YL, et al. A case-controlled study on the use of HbsAg-Positive donors for allogeneic hematopoietic cell transplantation. Blood 2000; 96: 452.
4. Strasser SI and McDonald GB. Hepatitis viruses and hematopoietic cell transplantation: A guide to patient and donor management. Blood 1999; 93: 1127.
5. De Franchis R, Hadengue A, Lau G, et al. EASL Jury. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol 2003; 39: S3.